-
1
-
-
33947379232
-
Impact of GPCRs in clinical medicine: Monogenic diseases, genetic variants and drug targets
-
Insel, P. A., Tang, C. M., Hahntow, I., and Michel, M. C. (2007) Impact of GPCRs in clinical medicine: Monogenic diseases, genetic variants and drug targets, Biochim Biophys Acta 1768, 994-1005
-
(2007)
Biochim Biophys Acta
, vol.1768
, pp. 994-1005
-
-
Insel, P.A.1
Tang, C.M.2
Hahntow, I.3
Michel, M.C.4
-
2
-
-
33947356279
-
G protein coupled receptor structure and activation
-
Kobilka, B. K. (2007) G protein coupled receptor structure and activation, Biochim Biophys Acta 1768, 794-807
-
(2007)
Biochim Biophys Acta
, vol.1768
, pp. 794-807
-
-
Kobilka, B.K.1
-
3
-
-
0038662595
-
Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors
-
Pin, J. P., Galvez, T., and Prezeau, L. (2003) Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors, Pharmacol Ther 98, 325-354
-
(2003)
Pharmacol Ther
, vol.98
, pp. 325-354
-
-
Pin, J.P.1
Galvez, T.2
Prezeau, L.3
-
4
-
-
19944411474
-
Allosteric modulation of the adenosine family of receptors
-
Gao, Z. G., Kim, S. K., Ijzerman, A. P., and Jacobson, K. A. (2005) Allosteric modulation of the adenosine family of receptors, Mini Rev Med Chem 5, 545-553
-
(2005)
Mini Rev Med Chem
, vol.5
, pp. 545-553
-
-
Gao, Z.G.1
Kim, S.K.2
Ijzerman, A.P.3
Jacobson, K.A.4
-
5
-
-
61349093537
-
Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders
-
Conn, P. J., Jones, C. K., and Lindsley, C. W. (2009) Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders, Trends Pharmacol Sci 30, 148-155
-
(2009)
Trends Pharmacol Sci
, vol.30
, pp. 148-155
-
-
Conn, P.J.1
Jones, C.K.2
Lindsley, C.W.3
-
6
-
-
19944402189
-
Allosteric modulation of dopamine receptors
-
Schetz, J. A. (2005) Allosteric modulation of dopamine receptors, Mini Rev Med Chem 5, 555-561
-
(2005)
Mini Rev Med Chem
, vol.5
, pp. 555-561
-
-
Schetz, J.A.1
-
7
-
-
34547697181
-
Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5
-
Leach, K., Charlton, S. J., and Strange, P. G. (2007) Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5, Biochem Pharmacol 74, 881-890
-
(2007)
Biochem Pharmacol
, vol.74
, pp. 881-890
-
-
Leach, K.1
Charlton, S.J.2
Strange, P.G.3
-
8
-
-
53049105136
-
Allosteric modulators of the human calcium-sensing receptor: Structures sites of action and therapeutic potentials
-
Hu, J. (2008) Allosteric modulators of the human calcium-sensing receptor: Structures, sites of action, and therapeutic potentials, Endocr Metab Immune Disord Drug Targets 8, 192-197
-
(2008)
Endocr Metab Immune Disord Drug Targets
, vol.8
, pp. 192-197
-
-
Hu, J.1
-
9
-
-
8844263762
-
Positive and negative allosteric modulation of metabotropic glutamate receptors: Emerging therapeutic potential
-
Kew, J. N. (2004) Positive and negative allosteric modulation of metabotropic glutamate receptors: Emerging therapeutic potential, Pharmacol Ther 104, 233-244
-
(2004)
Pharmacol Ther
, vol.104
, pp. 233-244
-
-
Kew, J.N.1
-
10
-
-
0347362886
-
The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism
-
Shoback, D. M., Bilezikian, J. P., Turner, S. A., McCary, L. C., Guo, M. D., and Peacock, M. (2003) The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism, J Clin Endocrinol Metab 88, 5644-5649
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 5644-5649
-
-
Shoback, D.M.1
Bilezikian, J.P.2
Turner, S.A.3
McCary, L.C.4
Guo, M.D.5
Peacock, M.6
-
11
-
-
30744447460
-
Efficacy of short-Term monotherapy with maraviroc a new CCR5 antagonist in patients infected with HIV-1
-
Fatkenheuer, G., Pozniak, A. L., Johnson, M. A., Plettenberg, A., Staszewski, S., Hoepelman, A. I., Saag, M. S., Goebel, F. D., Rockstroh, J. K., Dezube, B. J., Jenkins, T. M., Medhurst, C., Sullivan, J. F., Ridgway, C., Abel, S., James, I. T., Youle, M., and van der Ryst, E. (2005) Efficacy of short-Term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1, Nat Med 11, 1170-1172
-
(2005)
Nat Med
, vol.11
, pp. 1170-1172
-
-
Fatkenheuer, G.1
Pozniak, A.L.2
Johnson, M.A.3
Plettenberg, A.4
Staszewski, S.5
Hoepelman, A.I.6
Saag, M.S.7
Goebel, F.D.8
Rockstroh, J.K.9
Dezube, B.J.10
Jenkins, T.M.11
Medhurst, C.12
Sullivan, J.F.13
Ridgway, C.14
Abel, S.15
James, I.T.16
Youle, M.17
Van Der Ryst, E.18
-
12
-
-
33747181100
-
Allosteric agonists of 7TM receptors: Expanding the pharmacological toolbox
-
Langmead, C. J., and Christopoulos, A. (2006) Allosteric agonists of 7TM receptors: Expanding the pharmacological toolbox, Trends Pharmacol Sci 27, 475-481
-
(2006)
Trends Pharmacol Sci
, vol.27
, pp. 475-481
-
-
Langmead, C.J.1
Christopoulos, A.2
-
14
-
-
0020533362
-
Modification of the binding properties of muscarinic receptors by gallamine
-
Stockton, J. M., Birdsall, N. J., Burgen, A. S., and Hulme, E. C. (1983) Modification of the binding properties of muscarinic receptors by gallamine, Mol Pharmacol 23, 551-557
-
(1983)
Mol Pharmacol
, vol.23
, pp. 551-557
-
-
Stockton, J.M.1
Birdsall, N.J.2
Burgen, A.S.3
Hulme, E.C.4
-
15
-
-
0033945117
-
Allosteric interactions of staurosporine and other indolocarbazoles with N-[methyl-(3) H]scopolamine and acetylcholine at muscarinic receptor subtypes: Identification of a second allosteric site
-
Lazareno, S., Popham, A., and Birdsall, N. J. (2000) Allosteric interactions of staurosporine and other indolocarbazoles with N-[methyl-(3) H]scopolamine and acetylcholine at muscarinic receptor subtypes: Identification of a second allosteric site, Mol Pharmacol 58, 194-207
-
(2000)
Mol Pharmacol
, vol.58
, pp. 194-207
-
-
Lazareno, S.1
Popham, A.2
Birdsall, N.J.3
-
16
-
-
0037363728
-
Positive allosteric modulation of the human metabotropic glutamate receptor 4 (hmGluR4) by SIB-1893 and MPEP
-
Mathiesen, J. M., Svendsen, N., Brauner-Osborne, H., Thomsen, C., and Ramirez, M. T. (2003) Positive allosteric modulation of the human metabotropic glutamate receptor 4 (hmGluR4) by SIB-1893 and MPEP, Br J Pharmacol 138, 1026-1030
-
(2003)
Br J Pharmacol
, vol.138
, pp. 1026-1030
-
-
Mathiesen, J.M.1
Svendsen, N.2
Brauner-Osborne, H.3
Thomsen, C.4
Ramirez, M.T.5
-
17
-
-
0021058380
-
Operational models of pharmacological agonism
-
Black, J. W., and Leff, P. (1983) Operational models of pharmacological agonism, Proc R Soc Lond B Biol Sci 220, 141-162
-
(1983)
Proc R Soc Lond B Biol Sci
, vol.220
, pp. 141-162
-
-
Black, J.W.1
Leff, P.2
-
18
-
-
34447632041
-
Allosteric GPCR modulators: Taking advantage of permissive receptor pharmacology
-
Leach, K., Sexton, P. M., and Christopoulos, A. (2007) Allosteric GPCR modulators: Taking advantage of permissive receptor pharmacology, Trends Pharmacol Sci 28, 382-389
-
(2007)
Trends Pharmacol Sci
, vol.28
, pp. 382-389
-
-
Leach, K.1
Sexton, P.M.2
Christopoulos, A.3
-
19
-
-
70349336145
-
Growth hormone secretagogues and growth hormone releasing peptides act as orthosteric super-Agonists but not allosteric regulators for activation of the G protein Galpha(o1) by the Ghrelin receptor
-
Bennett, K. A., Langmead, C. J., Wise, A., and Milligan, G. (2009) Growth hormone secretagogues and growth hormone releasing peptides act as orthosteric super-Agonists but not allosteric regulators for activation of the G protein Galpha(o1) by the Ghrelin receptor, Mol Pharmacol 76, 802-811
-
(2009)
Mol Pharmacol
, vol.76
, pp. 802-811
-
-
Bennett, K.A.1
Langmead, C.J.2
Wise, A.3
Milligan, G.4
|